IP Library › Granted Patent US 12,488,882
Granted Patent B2
US 12,488,882 · App. 18/388,075 · Granted Dec 2, 2025

System and method for alerting providers to ineffective or under effective treatments based on genetic efficacy testing results

Inventors: Rob Todd (Doylestown, PA); Jerry Wrobel (Aurora, OH); John Pigott (Slyvania, OH)
Assignee: Xact Laboratories, LLC
G16H40/20C12Q1/6869G06F16/245G06F40/205G06Q10/10G06Q20/42G06Q30/016G06Q40/02G06Q40/08G16B35/20G16H10/40G16H10/60G16H70/40H04L63/0428
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,488,882
App. No.
18/388,075
Filed
Nov 8, 2023
Granted
Dec 2, 2025
Kind
B2
Art Unit
3683
USPC
705/2
Abstract

System and methods for alerting a healthcare provider to prescribed treatments having reduced or no effectiveness due to genetic composition is provided. A database containing treatments known to have reduced or no efficacy in persons having particular genetic markers is queried to determine whether any treatments prescribed by, or likely to be prescribed by, a healthcare provider to the patient are known to have reduced or no efficacy in persons having the same certain genetic markers as the patient. An alert indicating such information is displayed at a healthcare provider system.

Claims (97)

1 . A system for alerting a user to prescribed treatments likely to have reduced or no effectiveness due to genetic composition on a patient-specific basis, the system comprising:

an electronic network comprising:

healthcare affiliated nodes, said nodes including a healthcare provider system comprising electronic medical records data for patients treated by the healthcare provider, said electronic medical records data including data regarding patient identity and treatments prescribed by, or likely to be prescribed by, the healthcare provider to the patients and at least one pharmacy benefits manager system;

one or more databases comprising data regarding treatments known to have reduced or no efficacy in persons having particular genetic markers;

one or more genetic sequencing machines, each configured to accept genetic testing devices comprising genetic material for performing genetic testing in an automated fashion; and

one or more non-transitory electronic storage devices comprising software instructions, which when executed, configure one or more processors to, electronically and in an automated fashion:

receive orders for genetic testing from the healthcare provider system for at least some of the patients (“testing patients”), said orders comprising the patient identity data for the respective one of the testing patients;

in response to receiving said orders for genetic testing, operationally cause and control the automated assembly or modification of the genetic testing devices for the testing patients, including adding, removing, blocking, and/or unlocking wells of the genetic testing device to provide a patient-specific testing panel, and performance of the patient-specific genetic testing at the one or more genetic sequencing machines such that an order specific genetic testing device is generated for, and in accordance with, each of the received orders;

receive genetic testing results from the one or more genetic sequencing machines for testing patients;

generate, for each of the testing patients, a standardized file comprising standardized data indicating the genetic testing results from the one or more genetic sequencing machines for the respective one of the testing patients, each of said standardized files comprising structured data fields including the patient identity data for, and one or more genetic marker identifiers of, the respective one of the testing patients;

transmit the standardized files to the healthcare provider system for direct integration into the electronic medical records data;

electronically receive, for each of the testing patients, the patient identity data and data indicating the treatments prescribed to, or likely to be prescribed to, the testing patients (“treatment data”) from at least one of the healthcare affiliated nodes (“requesting node”) in a structured format;

query the one or more databases with the patient identity data and the treatment data to determine whether any of the treatments prescribed to, or likely to be prescribed to, the respective one of the testing patients is known to have reduced or no efficacy in persons having the same certain genetic markers as the respective one of the testing patients; and

automatically generate a standardized electronic alert for communication on the electronic network to one or more of the healthcare affiliated nodes, including the requesting node, said standardized electronic alert being interpretable by each of the healthcare affiliated nodes to indicate each of the treatments in the treatment data which are known to have reduced or no efficacy in persons having the same certain genetic markers as the patient as having reduced or no efficacy for the patient.

2 . The system of claim 1 wherein:

the healthcare affiliated nodes comprise a second healthcare provider system comprising electronic medical records data for patients treated by a second healthcare provider, said electronic medical records data including data regarding patient identity and treatments prescribed by, or likely to be prescribed by, the second healthcare provider to the patients, wherein at least one patient (“common patient”) treated by the second healthcare provider is common to the patents treated by the healthcare provider; and

the one or more electronic storage devices comprise additional software instructions, which when executed, configure the one or more processors to, electronically and in an automated fashion:

receive from at least one of the healthcare affiliated nodes of the electronic network (“additional requesting node”), the patient identity data for said common patient and a new treatment prescribed by, or likely to be prescribed by, the second healthcare provider to the common patient from the second healthcare provider system;

query the one or more databases with the new treatment to determine if the new treatment is known to have reduced or no efficacy in persons having the same certain genetic markers as the common patient; and

in response, generate and transmit to the electronic network, including the additional requesting node, the standardized electronic alert for the common patient which indicates whether any of said treatments prescribed, or likely to be prescribed, to said common patient by the second healthcare provider are known to have reduced or no efficacy in persons having the same certain genetic markers as the common patient.

3 . The system of claim 1 wherein:

said healthcare provider system comprises an electronic medical record system; and

the one or more electronic storage devices comprise additional software instructions, which when executed, configure the one or more processors to automatically cause said treatments prescribed, or likely to be prescribed, to each of said testing patients, on a patient specific basis, that are known to have reduced or no efficacy in persons having the same certain genetic markers as the patient to be designated as an allergy in an allergy field of the electronic medical record system upon receipt of the standardized file for the respective patient.

4 . The system of claim 1 wherein:

the healthcare provider system comprises electronically stored standardized diagnostic codes for each of said number of patients treated by the healthcare provider;

said one or more databases comprises data regarding alternative treatment options, each associated with at least one of the standardized diagnostic codes;

the one or more electronic storage devices comprise additional software instructions, which when executed, configure the one or more processors to query the one or more databases to retrieve certain of the alternative treatment options regarding alternative treatment options associated with the standardized diagnostic codes matching each condition diagnosed by the healthcare provider as recorded as one or more of the standardized diagnostic codes at the healthcare provider system known to normally require at least one of the treatments which is known to have reduced or no efficacy in persons having the same certain genetic markers as the patient for inclusion in the alert; and

the alert includes the alternative treatment options.

5 . The system of claim 1 wherein:

said one or more databases comprise standardized diagnostic codes and data regarding commonly prescribed treatments, wherein each of the standardized diagnostic codes is electronically associated with one or more of the commonly prescribed treatments;

said one or more electronic storage devices comprises additional software instructions, which when executed, configure the one or more processors to:

receive certain of the standardized diagnostic codes from the healthcare provider system for the patient; and

query the one or more databases to retrieve the commonly prescribed treatments associated with the received one or ones of the standardized diagnostic codes to determine the treatments likely to be prescribed to the patient; and

the treatment data used to query the one or more databases includes the commonly prescribed treatments.

6 . The system of claim 1 wherein:

one or more electronic storage devices and said one or more processors are part of a laboratory system;

said healthcare provider system, said one or more databases, and said laboratory system are remote from one another; and

said one or more genetic sequencing machines and said laboratory system are interconnected electronically by way of one or more local networks which form a portion of said electronic communications network.

7 . The system of claim 1 wherein:

the standardized electronic alert is provided in substantially real time.

8 . The system of claim 1 , wherein:

said one or more non-transitory electronic storage devices comprise additional software instructions, which when executed, configure said one or more processors to, electronically and in an automated fashion:

in response to receiving said orders for genetic testing:

generate optically scannable codes, each unique to a respective one of the testing patients and comprising embedded information regarding the patient identity data for the respective one of the testing patients, or associate existing optically scannable codes with the embedded information with the patient identity data, where said optically scannable codes are printed on or otherwise directly affixed to genetic material gathering devices and the genetic testing devices associated with the testing patients, on a patient-specific basis such that an order specific optically scannable code with order specific embedded information is provided for each of the received orders; and

receive the embedded information and the patient identity data from optical scanning of the optically scannable codes following return of the genetic material gathering devices, during the assembly or modification of the genetic testing devices, and during performance of the genetic testing at the one or more genetic sequencing machines and affiliate at least the patient identify data from the embedded information with the genetic testing results.

9 . The system of claim 1 , wherein:

the treatment data is received from the healthcare provider system; and

the treatment data is automatically generated upon adding, accessing, or modifying information regarding said treatments at the healthcare provider system.

10 . The system of claim 1 wherein:

said one or more non-transitory electronic storage devices comprise additional software instructions, which when executed, configure said one or more processors to, electronically and in an automated fashion: distribute the standardized electronic alerts to all of the healthcare affiliated nodes.

11 . The system of claim 1 wherein:

the one or more non-transitory electronic storage devices and the one or more processors are provided at one of the healthcare affiliated nodes of the electronic network.

12 . A computer-implemented method for automatically alerting an ordering healthcare provider and at least one non-ordering healthcare affiliated user to prescribed treatments having reduced or no efficacy for a respective patient based on the respective patient's genetic makeup, said method comprising the steps of:

receiving, at a laboratory system from a healthcare provider system, orders for genetic testing for certain patients treated by a first healthcare provider (“ordering provider”), said orders comprising patient information for each of the patients;

extracting, for each of said orders, identifying and testing information for the respective one of the patients;

generating, at the laboratory system, electronic, machine interpretable instructions for the automated assembly and/or modification of the genetic testing devices for the patients by way of one or more robots and for automated performance of the genetic testing at one or more genetic sequencing machines, including adding, removing, blocking, and/or unblocking wells thereof to prove a patient-specific panel in accordance with said orders;

transmitting, from the laboratory system to the one or more robots and the one or more genetic sequencing machines, said electronic, machine interpretable instructions, thereby directly causing and controlling the automated assembly or modification of the genetic testing devices for the patients by way of operational control of one or more components of the one or more robots and of the one or more genetic sequencing machines for the automated performance of the genetic testing threat using the genetic testing devices;

receiving, at the laboratory system, for each of the patients, data indicating genetic testing results from the one or more genetic sequencing machines indicating the presence and non-presence of tested for genetic markers for the patient treated by the ordering provider;

generating, at the laboratory system, for each of the patients, a standardized file indicating the genetic testing results, said standardized file including structured data fields including the identifying information for, and genetic markers of, the respective patient;

transmitting, from the laboratory system to the healthcare provider system, the standardized file for direct integration therewith;

providing, at the healthcare provider system, standardized data regarding treatments prescribed by, or likely to be prescribed by, the ordering provider to patients treated by the healthcare provider;

providing a database comprising data regarding treatments known to have reduced or no efficacy in persons having particular genetic markers;

providing a healthcare data distribution network comprising the healthcare provider system and a plurality of additional healthcare affiliated systems, each associated with a respective additional healthcare affiliated user (“non-ordering users”);

receiving data from one of the healthcare provider system and the plurality of addition healthcare affiliated systems, and by way of the healthcare data distribution network, indicating added, accessed, or modified ones of the treatments (“subset of treatments”) prescribed to, or likely to be prescribed to, a respective one of the patients, and subsequently automatically:

querying the database with the subset of treatments to determine if any of the subset of treatments are known to have reduced or no efficacy in persons having the same certain genetic markers as the respective patient;

generating and transmitting a standardized electronic alert, by way of the healthcare data distribution network, to at least one of the healthcare provider system for the respective patient and at least one of the plurality of additional healthcare affiliated systems indicating any the subset of treatments that are known to have reduced or no efficacy in persons having the same certain genetic markers as the patient, said systems and each of the plurality of additional healthcare affiliated systems.

13 . The method of claim 12 wherein:

at least the steps of querying the database and generating the standardized electronic alert are performed in substantially real time at the time of adding to, accessing, or modification the treatments at the healthcare provider system or any of the plurality of additional healthcare affiliated systems.

14 . The method of claim 12 further comprising:

generating, at the laboratory system, optically scannable codes, each unique to a respective one of the patients and comprising embedded information regarding the extracted identifying and testing information for the respective one of the patients, or associating existing optically scannable codes with said extracted identifying and testing information for the respective one of the patients, where each of said optically scannable codes are printed on, or otherwise affixed to, a respective genetic material gathering device and a respective genetic testing device such that an order specific optically scannable code with order specific embedded information is provided for each of the received orders;

receiving, at the one or more genetic sequencing machines and the one or more robots, the embedded information and extracted identifying and testing information for the respective one of the patients from optical scanning of the optically scannable codes from and following return of the genetic material gathering devices, and from and during the assembly or modification of the genetic testing devices, and during performance of the genetic testing at the one or more genetic sequencing machines from the genetic testing devices and affiliating the embedded information, including at least the identifying information, with the results from the genetic testing;

wherein the standardized data of the standardized file comprises the embedded information.

15 . A system for determining prescription drug efficacy in individual patients receiving medical treatment, based on genetic testing of the patient, said system comprising:

a healthcare electronic health record subsystem containing personal prescribed drug data for a plurality of patients;

at least one database including prescription drug efficacy data relative to human genetic characteristics data;

a genetic testing subsystem comprising genetic sequencing machines, robots for assembling or modifying genetic testing devices for the genetic sequencing machines, including added, removing, blocking, and/or unblocking wells thereof in accordance with received orders, and one or more processors for receiving the order and exerting operational control over operations of the genetic sequencing machines and the robots including movements thereof, to cause an order specific genetic testing device to be generated for, and in accordance with, each of the received orders, performance of genetic testing on individual patient test samples provided at genetic material gathering devices and transferred to genetic testing devices at the genetic sequencing machines, and electronically delivery of genetic characteristics results for individual ones of said patients;

a data analysis subsystem in electronic communication with said at least one database and said genetic testing subsystem, and including at least one processor programmed to compare, in response to a series of standardized, inter-network electronic communication queries from a requesting electronic system, a respective one of the plurality of patient's individual genetic characteristic result data to data from said healthcare electronic record subsystem indicating one or more prescription drugs prescribed for said patient, and determine efficacy of said one or more prescription drugs for said patient based on said patient's genetic characteristic result, and to automatically notify said healthcare electronic health record for said patient that a prescribed drug is not efficacious for said patient using at least one standardized electronic alert; and

an electronic data communication network that facilitates electronic data communication in a secured, encrypted, and standardized format among the health record subsystem, the at least one database, the data analysis subsystem, the genetic testing subsystem, and the requesting electronic system including through a subnetwork thereof and with transmission of files in the secured, encrypted, standardized format for intra-compatibility, wherein the standardized electronic alert is accepted within, and interpretable within, the electronic data communication network to indicated genetic efficacy contraindication.

16 . The system of claim 15 , wherein:

said electronic health record subsystem resides on a healthcare provider legacy system;

said electronic communication network includes a legacy pharmacy benefits system as the requesting electronic system; or

said electronic communication network includes a legacy healthcare insurance benefits subsystem as the requesting electronic system.

17 . The system of claim 15 , wherein:

said electronic communication network includes a pharmacy subsystem and a healthcare insurance benefits subsystem, at least one of which is the requesting electronic stem; and

said communication network includes an intermediary electronic communications subsystem between the pharmacy subsystem and the healthcare insurance benefits subsystem as the requesting electronic system.

18 . The system of claim 15 , further comprising:

a second healthcare electronic health record subsystem containing personal prescribed drug data for a second plurality of patients, where at least said patient is common to the second plurality of patients and the plurality of patients, wherein the data analysis subsystem is in electronic communication with the second healthcare electronic health record subsystem and said at least one process is further programmed to compare said patient's genetic characteristic result data to data from said second healthcare electronic health record subsystem indicating one or more additional prescription drugs prescribed for said patient.

19 . A computerized system for drug contraindication notification, comprising:

a laboratory subsystem comprising at least one robot, at least one genetic sequencing machine, and at least one processor exercising operational control over the at least one robot and the at least one genetic sequencing machine to carry out ordered genetic testing for patients in an at least partially automated fashion;

a drug database of drug contraindications based on PGx test results;

a patient PGx electronic test result from the ordered genetic testing for a respective one of the patients received from the laboratory system;

a processor adapted to analyze the patient PGx electronic test result and the drug database using a series of standardized electronic queries to the drug database, and automatically generate a standardized electronic alert where at least one drug is found to be contraindicated based on the series of standardized electronic queries; and,

an electronic interface adapted to transmit the standardized electronic alert into an electronic record for the patient, at a first computer node on a wide area medical affiliated computer network of nodes, the standardized electronic alert being acceptable by, and interpretable by, each of the nodes of the medical affiliated computer network;

wherein said standardized electronic alert is electronically delivered to a second computer node in the wide area medical affiliated computer network.

20 . The system of claim 19 , wherein said first node is a pharmacy benefits manager (PBM) computer node.

21 . The system of claim 20 , wherein said second node is a pharmacy computer node.

22 . The system of claim 20 , wherein said second node is a care provider computer node.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2023
From: TODD, ROB; WROBEL, JERRY; PIGOTT, JOHN
To: XACT LABORATORIES, LLC
Reel/Frame 065500/0203 →
Continuity (7)
Continuation 17553096 · Dec 16, 2021
Continuation 16848458 · Apr 14, 2020
Continuation In Part 16674189 · Nov 5, 2019
Continuation In Part 16441597 · Jun 14, 2019
Provisional Application 62773424 · Nov 30, 2018
Provisional Application 62685479 · Jun 15, 2018
Related Publication 20240079120A1 · Mar 7, 2024
References Cited (91)
US 6315720B1 · Williams et al. · 2001 [cited by applicant]
US 8386274B1 · Pinsonneault · 2013 [cited by applicant]
US 10950354B1 · Belgoroski · 2021 [cited by applicant]
US 11281194B1 · Fernando · 2022 [cited by applicant]
US 11527331B2 · Todd · 2022 [cited by applicant]
US 11626191B1 · Gartner · 2023 [cited by applicant]
US 20020012921A1 · Stanton, Jr. · 2002 [cited by applicant]
US 20020052761A1 · Fey et al. · 2002 [cited by applicant]
US 20020115073A1 · Papadopoulos et al. · 2002 [cited by applicant]
US 20020147616A1 · Pollard et al. · 2002 [cited by applicant]
US 20020187483A1 · Hoffman et al. · 2002 [cited by applicant]
US 20030040002A1 · Ledley · 2003 [cited by applicant]
US 20030046110A1 · Gogolak · 2003 [cited by applicant]
US 20030073124A1 · Bowman et al. · 2003 [cited by applicant]
US 20050026117A1 · Judson · 2005 [cited by examiner]
US 20050107672A1 · Lipscher · 2005 [cited by examiner]
US 20050149361A1 · Saus et al. · 2005 [cited by applicant]
US 20060178843A1 · Athanasiou · 2006 [cited by applicant]
US 20060259325A1 · Patterson · 2006 [cited by applicant]
US 20070178501A1 · Rabinowitz et al. · 2007 [cited by applicant]
US 20080091464A1 · Lipscher · 2008 [cited by examiner]
US 20080131887A1 · Stephan et al. · 2008 [cited by applicant]
US 20080162352A1 · Gizewski · 2008 [cited by applicant]
US 20080228824A1 · Kenedy · 2008 [cited by applicant]
US 20090094059A1 · Coleman et al. · 2009 [cited by applicant]
US 20090198519A1 · McNamar · 2009 [cited by applicant]
US 20090240523A1 · Friedlander · 2009 [cited by applicant]
US 20100070455A1 · Halperin et al. · 2010 [cited by applicant]
US 20100317006A1 · Soykan et al. · 2010 [cited by applicant]
US 20110113002A1 · Kane · 2011 [cited by applicant]
US 20110282690A1 · Patel · 2011 [cited by applicant]
US 20120065999A1 · Takatoku et al. · 2012 [cited by applicant]
US 20120185270A1 · Scantland et al. · 2012 [cited by applicant]
US 20130096943A1 · Carey · 2013 [cited by examiner]
US 20130226621A1 · Van Der Zaag et al. · 2013 [cited by applicant]
US 20130246079A1 · Hoffman · 2013 [cited by examiner]
US 20140012843A1 · Soon-Shiong · 2014 [cited by applicant]
US 20140211204A1 · Stedtfeld · 2014 [cited by applicant]
US 20140244309A1 · Francois · 2014 [cited by examiner]
US 20140303992A1 · Scantland et al. · 2014 [cited by applicant]
US 20140316821A1 · Sheffield et al. · 2014 [cited by applicant]
US 20140350954A1 · Ellis et al. · 2014 [cited by applicant]
US 20140372141A1 · Renner et al. · 2014 [cited by applicant]
US 20150058030A1 · Scantland et al. · 2015 [cited by applicant]
US 20150058039A1 · Shiloh · 2015 [cited by applicant]
US 20150170291A1 · Renner et al. · 2015 [cited by applicant]
US 20150228030A1 · Scantland et al. · 2015 [cited by applicant]
US 20160048652A1 · Spivey et al. · 2016 [cited by applicant]
US 20160092652A1 · Stewart et al. · 2016 [cited by applicant]
US 20160180063A1 · Scantland et al. · 2016 [cited by applicant]
US 20160239636A1 · O'Donnell et al. · 2016 [cited by applicant]
US 20170004282A1 · Scantland et al. · 2017 [cited by applicant]
US 20170046491A1 · Scantland et al. · 2017 [cited by applicant]
US 20170046492A1 · Renner et al. · 2017 [cited by applicant]
US 20170124254A1 · van Rooyen · 2017 [cited by applicant]
US 20170213011A1 · Hoffman · 2017 [cited by examiner]
US 20170270246A1 · Baskys · 2017 [cited by applicant]
US 20170293722A1 · Valverde, Jr. · 2017 [cited by applicant]
US 20170308669A1 · Apte et al. · 2017 [cited by applicant]
US 20180075220A1 · Hill, Sr. et al. · 2018 [cited by applicant]
US 20180308569A1 · Luellen · 2018 [cited by applicant]
US 20180330060A1 · Biles et al. · 2018 [cited by applicant]
US 20180330824A1 · Athey et al. · 2018 [cited by applicant]
US 20190244688A1 · Wilson et al. · 2019 [cited by applicant]
US 20190385747A1 · Todd · 2019 [cited by examiner]
US 20200160958A1 · Huser · 2020 [cited by examiner]
US 20200365280A1 · Todd · 2020 [cited by applicant]
US 20210319871A1 · Hanz · 2021 [cited by applicant]
WO 2013096729A2 · 2013 [cited by applicant]
Clinisync, Clinisync Products and Services webpage, http://www.clinisync.org/, Jul. 18, 2018, 5 pages. [cited by applicant]
Althoff, Lisa, DNA Chip—Genetic Testing of the Future webpage, https://www.ndsu.edu/pubweb/˜mcclean/plsc431/students99/althoff.html, Copyright 1999, Aug. 2, 2019, 5 pages. [cited by applicant]
LabX, DNA Sequencers Listings webpage, https://www.labx.com/dna-sequencers, Aug. 2, 2019, 3 pages. [cited by applicant]
Vecna, Vecna Patient Solutions webpage, https://healthcare.vecna.com/, Jul. 18, 2019, 11 pages. [cited by applicant]
Translational Software, Making Sense of Pharmacogenomics Testing webpage, https://translationalsoftware.com/, Sep. 11, 2019, 14 pages. [cited by applicant]
Translational Software, Integrated Into Clinical Systems archived webpage, https://web.archive.org/web/20171217010330/https://translationalsoftware.com/, Oct. 17, 2017, 7 pages. [cited by applicant]
Translational Software, Insights Ready for Action archived webpage, https://web.archive.org/web/20180829020620/https://translationalsoftwarre.com/, Aug. 29, 2018, 9 pages. [cited by applicant]
Coriell Life Sciences, GeneDose—Medication Risk Management Tool archived webpage, https://web.archive.org/web/20170611205541/http://genedose.com/, Jun. 11, 2017, 8 pages. [cited by applicant]
Coriell Life Sciences, DNA-Driven Diagnostics to Guide Clinical Decision-Making webpage, https://www.coriell.com/genetic-interpretation-reportiong/, Sep. 11, 2019, 9 pages. [cited by applicant]
Coriell Life Services, GeneDose Youtube Video, https://youtube.com/watch?v=tku6_9tADuw, Sep. 11, 2019. [cited by applicant]
Caraballo et al., Electronic Medical Record-Integrated Pharmacogenomics and Related Clinical Decision Support Concepts, Aug. 2017, Clinical Pharmacology & Therapeutics, vol. 102 No 2, pp. 254-264. [cited by applicant]
McCain, Lauren Ann, A Policy Appraisal of the United States Human Genome Project, Order No. 3096828, University of Colorado at Boulder, 2003. [cited by applicant]
Hinderer et al., Integrating clinical decision support systems for pharmacogenomic testing into clinical routine—a scoping review of designs of user-system interactions in recent system development, research article, Ju… [cited by applicant]
Hicks et al., Integrating pharmacogenomics into electronic health records with clinical decision support, author manuscript, Dec. 1, 2016, 17 pages. [cited by applicant]
Peterson et al., Electronic Health Record Design and Implementation for Pharmacogenomics: a local perspective, Oct. 2013, Genetics in Medicine, vol. 15 No 10. [cited by applicant]
Jensen, Peter, et al., Mining Electronic Health Records: Towards Better Research Applications and Clinical Care, Translational Genetics, Nature Reviews: Genetics, vol. 13, Jun. 2012, pp. 395-405. [cited by applicant]
Sutter Community Connect, Cancel Rx and Change Rx, Tip Sheet, AMB Clinicians, Dec. 10, 2019, 7 pgs. [cited by applicant]
DrFirst, DrFirst Launches myBenefitCheck Real-Time Benefit Check Capabilities to Help Patients Better Manage Medication Costs and Adherence DrFirst, Press Release, Oct. 22, 2015, 5 pgs., DrFirst Healthcare Innovations, … [cited by applicant]
AVS Medical, NextGen Office Adds ChangeRX and Cancel RX to Their Cloud Based EHR, AVS—Blog, Mar. 1, 2019, 1 pg. [cited by applicant]
Surescripts, Real-Time Benefit Check: Enhancing Provider and Patient Choice from Within the EHR, 2 pgs. [cited by applicant]
Covermymeds, RxBenefit Clarity: Empowering Providers and Their Patients with Prescription Price Transparency, Feb. 9, 2022, 13 pgs. [cited by applicant]
Naples, Eric C., What Does CMS' Real-Time Benefit Tool Final Rule Mean for the Healthcare Industry?, Blog, Jan. 22, 2020, 7 pgs., RxRevu, Inc. [cited by applicant]
Cited By (1)
US 12,694,956